Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03799263Unknown

A Six Minute Walking Test Based Index as an Outcome Predictor in COPD Subjects. (Chronic Obstructive Pulmonary Disease)

Role: lead

NCT03922789Completed

Minimal Important Difference of Walking Test in Subjects With Bronchial Asthma

Role: lead

NCT02640430Not ApplicableCompleted

Randomized Trial of the FreeAspire Versus PEP-bottle After Acute Exacerbation in COPD Patients

Role: lead

NCT03644121Completed

Adherence to CPAP in Patients With OSA. Ten Year Follow up

Role: lead

NCT02487875Not ApplicableCompleted

Sit-to-stand and Peripheral Muscle Strength in COPD

Role: lead

All 5 trials loaded